Biotech · Private company
VivaVision Biotech, Inc
Track this companyFree. Adds VivaVision Biotech, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- VehiclePhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · InflammationClinicalTrials.gov · fetched Nov 12, 2026
- VVN001 Ophthalmic Solution 1%Phase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- VVN001 Ophthalmic Solution 5%Phase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- VVN461 Ophthalmic Solution 0.5%Phase 2 · InflammationClinicalTrials.gov · fetched Nov 12, 2026
- VVN461 Ophthalmic Solution 1.0%Phase 2 · InflammationClinicalTrials.gov · fetched Nov 12, 2026
- VVN539 Ophthalmic Solution 0.02%Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- VVN539 Ophthalmic Solution 0.04%Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- VVN539 Ophthalmic Solution VehiclePhase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract SurgeryPHASE2 · COMPLETED · started Jan 11, 2024ClinicalTrials.gov NCT06164743 · fetched Nov 12, 2026
- A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular PressurePHASE2 · COMPLETED · started Jul 12, 2022ClinicalTrials.gov NCT05451329 · fetched Nov 12, 2026
- Study of VVN001 Ophthalmic Solution in Dry Eye DiseasePHASE2 · COMPLETED · started Dec 3, 2020ClinicalTrials.gov NCT04556838 · fetched Nov 12, 2026